Literature DB >> 6773105

External irradiation for malignant thyroid tumors.

C T Chung, R H Sagerman, M C Ryoo, G A King, W S Yu, P S Dalal, I G Emmanuel.   

Abstract

Thirty-eight patients with residual or recurrent primary thyroid cancers which did not take up 1-131 were treated with external beam irradiation. Excluding 5 patients with malignant lymphoma, there were 23 patients with local disease and 10 with distant metastases. Doses ranged from 3,500 to 7,000 rads (35-70 Gy) among the 23 with local disease; local tumor control was achieved in 8. Six are alive and well 2-11 years later. External beam irradiation should be considered in locally advanced, incompletely resected, recurrent and metastatic thyroid malignancies of all histological types without 1-131 uptake. Reviewed are the age and sex distribution, histology, stage, extent of surgery, and dose and radiotherapy technique as they affect survival and patterns of failure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773105     DOI: 10.1148/radiology.136.3.6773105

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Management of tracheal obstruction from thyroid diseases.

Authors:  B Cady
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

2.  Treatment of radioiodine-negative bone metastasis from papillary thyroid carcinoma with percutaneous ethanol injection therapy.

Authors:  K Nakada; K Kasai; Y Watanabe; C Katoh; K Kanegae; E Tsukamoto; K Itoh; N Tamaki
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

3.  Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.

Authors:  David L Schwartz; Mark J Lobo; K Kian Ang; William H Morrison; David I Rosenthal; Anesa Ahamad; Douglas B Evans; Gary Clayman; Steven I Sherman; Adam S Garden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-25       Impact factor: 7.038

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.